These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15313907)

  • 1. Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma.
    Meng J; Tsai-Morris CH; Dufau ML
    Cancer Res; 2004 Aug; 64(16):5677-82. PubMed ID: 15313907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short form 1b human prolactin receptor down-regulates expression of the long form.
    Tan D; Walker AM
    J Mol Endocrinol; 2010 Mar; 44(3):187-94. PubMed ID: 19906835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization.
    Qazi AM; Tsai-Morris CH; Dufau ML
    Mol Endocrinol; 2006 Aug; 20(8):1912-23. PubMed ID: 16556730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could prolactin receptor gene polymorphism play a role in pathogenesis of breast carcinoma?
    Canbay E; Degerli N; Gulluoglu BM; Kaya H; Sen M; Bardakci F
    Curr Med Res Opin; 2004 Apr; 20(4):533-40. PubMed ID: 15119991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
    Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
    J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines.
    Treeck O; Juhasz-Boess I; Lattrich C; Horn F; Goerse R; Ortmann O
    Breast Cancer Res Treat; 2008 Aug; 110(3):507-20. PubMed ID: 17876701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin receptors in human breast cancer cells in long-term tissue culture.
    Shiu RP
    Cancer Res; 1979 Nov; 39(11):4381-6. PubMed ID: 227585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluation of the prolactin receptor expression in human breast cancer.
    Galsgaard ED; Rasmussen BB; Folkesson CG; Rasmussen LM; Berchtold MW; Christensen L; Panina S
    J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of HOX genes in human invasive breast carcinoma.
    Makiyama K; Hamada J; Takada M; Murakawa K; Takahashi Y; Tada M; Tamoto E; Shindo G; Matsunaga A; Teramoto K; Komuro K; Kondo S; Katoh H; Koike T; Moriuchi T
    Oncol Rep; 2005 Apr; 13(4):673-9. PubMed ID: 15756441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
    Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
    Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin.
    Kang JH; Hassan SA; Zhao P; Tsai-Morris CH; Dufau ML
    Biochim Biophys Acta; 2014 Jul; 1840(7):2272-80. PubMed ID: 24735798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.
    Girault I; Andrieu C; Tozlu S; Spyratos F; Bièche I; Lidereau R
    Cancer Lett; 2004 Nov; 215(1):101-12. PubMed ID: 15374639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin.
    Trott JF; Horigan KC; Gloviczki JM; Costa KM; Freking BA; Farmer C; Hayashi K; Spencer T; Morabito JE; Hovey RC
    J Endocrinol; 2009 Jul; 202(1):153-66. PubMed ID: 19401343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.
    Veeck J; Geisler C; Noetzel E; Alkaya S; Hartmann A; Knüchel R; Dahl E
    Carcinogenesis; 2008 May; 29(5):991-8. PubMed ID: 18356147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
    Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
    Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments.
    Harvey PW
    J Appl Toxicol; 2005; 25(3):179-83. PubMed ID: 15856525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
    Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.